Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulrike Protzer

Showing results (61-70 of 308) with videos related to

Pageof 31
Sort By:
Antiviral Research|July 20, 2021
Intramolecular recombination enables the formation of hepatitis B virus (HBV) cccDNA in mice after HBV genome transfer using recombinant AAV vectorsChunkyu Ko, Jinpeng Su, Julia Festag, et al.
Journal of Immunology Research|April 4, 2017
Secreted Interferon-Inducible Factors Restrict Hepatitis B and C Virus Entry In VitroYuchen Xia, Xiaoming Cheng, Christoph K Blossey, et al.
Scientific Reports|October 6, 2021
Concentration of Na<sup>+</sup>-taurocholate-cotransporting polypeptide expressed after in vitro-transcribed mRNA transfection determines susceptibility of hepatoma cells for hepatitis B virusAndreas Oswald, Anindita Chakraborty, Yi Ni, et al.
Molecular Immunology|August 28, 2023
Modeling of the human interleukin 12:receptor complex allows to engineer attenuated cytokine variantsKorbinian Liebl, Isabel Aschenbrenner, Lisa Schiller, et al.
Frontiers in Immunology|November 21, 2022
Activation of distinct antiviral T-cell immunity: A comparison of bi- and trispecific T-cell engager antibodies with a chimeric antigen receptor targeting HBV envelope proteinsBilge Debelec-Butuner, Oliver Quitt, Sophia Schreiber, et al.
Vaccines|January 20, 2021
Linear B-Cell Epitopes in Human Norovirus GII.4 Capsid Protein Elicit Blockade AntibodiesHassan Moeini, Suliman Qadir Afridi, Sainitin Donakonda, et al.
Antiviral Research|January 9, 2018
Lipase inhibitor orlistat prevents hepatitis B virus infection by targeting an early step in the virus life cycleKnud Esser, Julie Lucifora, Jochen Wettengel, et al.
Cells|April 3, 2021
Increased HERV-K(HML-2) Transcript Levels Correlate with Clinical Parameters of Liver Damage in Hepatitis C PatientsMelanie Weber, Vidya Padmanabhan Nair, Tanja Bauer, et al.
Viruses|August 28, 2021
Rapid and Robust Continuous Purification of High-Titer Hepatitis B Virus for In Vitro and In Vivo ApplicationsJochen M Wettengel, Bianca Linden, Knud Esser, et al.
Antiviral Research|April 28, 2024
The lack of HBsAg secretion does neither facilitate induction of antiviral T cell responses nor Hepatitis B Virus clearance in miceThomas Michler, Jakob Zillinger, Philipp Hagen, et al.
Pageof 31

Showing results (61-70 of 308) with videos related to

Sort By:
Pageof 31
Antiviral Research|July 20, 2021
Intramolecular recombination enables the formation of hepatitis B virus (HBV) cccDNA in mice after HBV genome transfer using recombinant AAV vectorsChunkyu Ko, Jinpeng Su, Julia Festag, et al.
Journal of Immunology Research|April 4, 2017
Secreted Interferon-Inducible Factors Restrict Hepatitis B and C Virus Entry In VitroYuchen Xia, Xiaoming Cheng, Christoph K Blossey, et al.
Scientific Reports|October 6, 2021
Concentration of Na<sup>+</sup>-taurocholate-cotransporting polypeptide expressed after in vitro-transcribed mRNA transfection determines susceptibility of hepatoma cells for hepatitis B virusAndreas Oswald, Anindita Chakraborty, Yi Ni, et al.
Molecular Immunology|August 28, 2023
Modeling of the human interleukin 12:receptor complex allows to engineer attenuated cytokine variantsKorbinian Liebl, Isabel Aschenbrenner, Lisa Schiller, et al.
Frontiers in Immunology|November 21, 2022
Activation of distinct antiviral T-cell immunity: A comparison of bi- and trispecific T-cell engager antibodies with a chimeric antigen receptor targeting HBV envelope proteinsBilge Debelec-Butuner, Oliver Quitt, Sophia Schreiber, et al.
Vaccines|January 20, 2021
Linear B-Cell Epitopes in Human Norovirus GII.4 Capsid Protein Elicit Blockade AntibodiesHassan Moeini, Suliman Qadir Afridi, Sainitin Donakonda, et al.
Antiviral Research|January 9, 2018
Lipase inhibitor orlistat prevents hepatitis B virus infection by targeting an early step in the virus life cycleKnud Esser, Julie Lucifora, Jochen Wettengel, et al.
Cells|April 3, 2021
Increased HERV-K(HML-2) Transcript Levels Correlate with Clinical Parameters of Liver Damage in Hepatitis C PatientsMelanie Weber, Vidya Padmanabhan Nair, Tanja Bauer, et al.
Viruses|August 28, 2021
Rapid and Robust Continuous Purification of High-Titer Hepatitis B Virus for In Vitro and In Vivo ApplicationsJochen M Wettengel, Bianca Linden, Knud Esser, et al.
Antiviral Research|April 28, 2024
The lack of HBsAg secretion does neither facilitate induction of antiviral T cell responses nor Hepatitis B Virus clearance in miceThomas Michler, Jakob Zillinger, Philipp Hagen, et al.
Pageof 31